FLI1 and neoplasm: Over the past several years, independent findings from multiple labs have shown that the levels of EWS::FLI1 expression and transcriptional activity vary among individual tumor cells and this variability is emerging as a critical determinant of epigenetic plasticity, tumor cell phenotype, and disease progression (17–25).